Implications of cancer stem cells in the treatment of cancer (Q36677482)

15 August 2017

1 reference

title

Implications of cancer stem cells in the treatment of cancer (English)

1 reference

15 August 2017

main subject

neoplastic stem cells

1 reference

Chong-Xian Pan

1

1 reference

15 August 2017

Wei Zhu

series ordinal

2

1 reference

15 August 2017

Liang Cheng

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

723-731

1 reference

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Characterization of clonogenic multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Characterization of a side population of cancer cells from human gastrointestinal system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Acute promyelocytic leukemia: where does it stem from?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Direct isolation of human central nervous system stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

CD133, a novel marker for human prostatic epithelial stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Expression of Thy-1 on human hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Isolation of a candidate human hematopoietic stem-cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

The multiple roles of PTEN in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Stem cells find their niche

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

The stem-cell niche theory: lessons from flies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Normal stem cells and cancer stem cells: the niche matters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Stem cell niche: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Metastatic patterns in adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

Epidermal growth factor receptor and Ink4a/Arf

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.6.723

21 January 2018

Identifiers

DOI

10.2217/14796694.2.6.723

1 reference

15 August 2017

1 reference